Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Eli Lilly Strikes Partnership to Offer Discounted Insulin

By Ryan Bushey | December 13, 2016

Eli Lilly will launch a new program in conjunction with Express Scripts to offer diabetes patients lower prices for its insulin products.

Customers can access these discounts through a startup called Blink Health where they could save up to 40 percent off the full retail price at pharmacies.

Humalog, Basaglar, and a new long-acting biologic being developed by Lilly and Boehringer Ingelheim will be included in this program, reported Reuters.

Patients would simply need to use Blink’s mobile or web platforms to fill out a form providing prescription details like dosage and quantity of the insulin, pay for the medication online, and then pick it up at any U.S. pharmacy found in Blink’s network.

This partnership comes after growing public scrutiny over the rising prices for the life-saving diabetes treatment, according to The Wall Street Journal (WSJ). Top selling insulins have had their prices more than double in a five year period.

Eli Lilly explained in its announcement that it held meetings over several months with multiple leaders in the diabetes community to discuss the price of insulin in an effort to help create this program.

“The health care system is incredibly complex, and we hope this program is a first step that will drive more thinking and innovative solutions for people with diabetes,” said president of Eli Lilly’s diabetes division Enrique Conterno, in a statement. “A more extensive solution will require leadership and cooperation across many stakeholders, including manufacturers, pharmacy benefit managers, insurers and patients.  We’re committed to seeking additional solutions so that everyone who uses insulin has reasonable access.”

Primary beneficiaries of this program will be individuals who don’t have health insurance or who are in the deductible-paying part of high-deductible insurance plans, explained WSJ.

It officially goes into effect January 1st, 2017.


Filed Under: Drug Discovery

 

Related Articles Read More >

Lokavant’s Spectrum v15 uses AI to cut trial-feasibility modeling from weeks to minutes
Prime time for peptide-based drug discovery 
Why smaller, simpler molecular glues are gaining attention in drug discovery
Glass vial, pipette and woman scientist in laboratory for medical study, research or experiment. Test tube, dropper and professional female person with chemical liquid for pharmaceutical innovation
Unlocking ‘bench-to-bedside’ discoveries requires better data sharing and collaboration
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE